833-2263234 (USA Toll-free) +1-224-345-1927 (USA) +86-13250544625(Intl) info@editxor.com
在线客服
[Weekly News] CRISPR-Cas9 Screening Technology Breaks Through the Limitations of Functional Genomic S

[Weekly News] CRISPR-Cas9 Screening Technology Breaks Through the Limitations of Functional Genomic S

EDITGENE focuses on CRISPR technology and is dedicated to providing the most efficient technical services for CRISPR-related research, gene function studies, in vitro diagnostics, and therapeutic research.

[Literature Review] CRISPR Knockout: A Breakthrough in Nrf2 Activation for Kidney Disease Treatment

[Literature Review] CRISPR Knockout: A Breakthrough in Nrf2 Activation for Kidney Disease Treatment

EDITGENE focuses on gene editing, offering highly efficient gene knock-out services using an upgraded CRISPR/Cas9 system, which provides a higher positive rate and broader applicability across gene loci

[Weekly News] New Breakthrough in Cas Enzyme Structure: The First Structure of Type I-C NlaCas3 Enzym

[Weekly News] New Breakthrough in Cas Enzyme Structure: The First Structure of Type I-C NlaCas3 Enzym

EDITGENE focuses on CRISPR technology and is dedicated to providing the most efficient technical services for CRISPR-related research, gene function studies, in vitro diagnostics, and therapeutic research.

[Literature Review] Deadly RNA: CRISPR Screening Reveals RP11-350G8.5 as a Key Target for Multiple My

[Literature Review] Deadly RNA: CRISPR Screening Reveals RP11-350G8.5 as a Key Target for Multiple My

EDITGENE offers a complete one-stop solution for CRISPR library screening, specializing in gene editing for over a decade. We have assembled the most popular CRISPR sgRNA library types in the research community, complemented by our expert team’s attentive service. Everything is …

Prev 1 2 3 4 5 6 7 8 9 10 11 Next